DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $12,415.50 under an indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items. The order calls for the delivery of 4562816512 PERJETA 420 MG/14 ML VIAL 14ML to be completed by December 4, 2023. DMS Pharmaceutical Group will provide the requested pharmaceutical products to the Defense Logistics Agency as the prime contractor. No set-aside designation was used for this award. DMS Pharmaceutical Group currently holds an indefinite delivery contract with the Defense Logistics Agency valued at up to $5 million to supply various medical supplies including atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, and midazolam hydrochloride through December 2025. Delivery orders against this vehicle are issued on a firm fixed price basis to support the routine needs of military treatment facilities worldwide.
Generated 2/8/24, 10:22 AM